PROFOUND MEDICAL CORP. Current Lease Liabilities
PROFOUND MEDICAL CORP. (PROF) had Current Lease Liabilities of $259.00 thousand as of 2023-12-31, per its 40-F filed 2024-03-07.
Discontinued › Notes › Leases
ifrs-full:CurrentLeaseLiabilities · last filed 2024-03-07
- 2019-12-31: Current Lease Liabilities 259.00K CAD; Current Lease Liabilities as first filed 258.69K CAD.
CAD
| Period end | Current Lease Liabilities | Current Lease Liabilities as first filed |
|---|---|---|
| 2019-12-31 | 259.00K CAD 40-F · filed 2021-03-02 | 258.69K CAD 40-F · filed 2020-03-03 |
USD
| Period end | Current Lease Liabilities |
|---|---|
| 2023-12-31 | $259.00K 40-F · filed 2024-03-07 |
| 2022-12-31 | $239.00K 40-F · filed 2024-03-07 |
| 2021-12-31 | $250.00K 40-F · filed 2023-03-07 |
| 2020-12-31 | $312.00K 40-F · filed 2022-03-03 |
| 2019-12-31 | $199.00K 40-F · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |